NEU neuren pharmaceuticals limited

Ann: Q2 2024 update, page-5

  1. 4,012 Posts.
    lightbulb Created with Sketch. 986
    Chill everyone! Look at this as a super buying opportunity. The sky is not falling in for Daybue.

    2014
    1st Q sales US$75.9m
    2nd Q sales US$84.6m

    Sales are heading in the right direction, (they have not dropped), just a little slower increase than originally forecast.

    Even if Daybue sales only hit the lower end of the revised full year guidance of US$340m - US$370m, that still importantly results in 2nd half sales to be US$180m up from US$160m for1st Half.

    Still excellent results from a new product with plenty of upside IMO. Milestone payments to come.
    And that’s just the good news for Daybue….
    Last edited by sarge17: 07/08/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.